Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (se deschide o fereastră nouă)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Sursă‎: Pediatr Transplant 2017;21(6):e13017.

Index‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (se deschide o fereastră nouă)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (se deschide o fereastră nouă)

Bhatia M, Davenport V, Cairo MS.

Sursă‎: Leuk Lymphoma 2007;48(1):9-15.

Index‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (se deschide o fereastră nouă)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (se deschide o fereastră nouă)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Sursă‎: Lancet 2003;361(9354):275-80.

Index‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (se deschide o fereastră nouă)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (se deschide o fereastră nouă)

Fassel H, Bussel JB, Roberts SS, Modak S

Sursă‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Index‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (se deschide o fereastră nouă)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (se deschide o fereastră nouă)

Jacobson AE, Shah N, Setty BA

Sursă‎: Pediatr Blood Cancer 2017;64(8):e26473.

Index‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (se deschide o fereastră nouă)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (se deschide o fereastră nouă)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Sursă‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Index‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (se deschide o fereastră nouă)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (se deschide o fereastră nouă)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Sursă‎: Int J Hematol 2015;102(5):626-32.

Index‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (se deschide o fereastră nouă)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (se deschide o fereastră nouă)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Sursă‎: J Pediatr 1996;129(5):656-60.

Index‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (se deschide o fereastră nouă)

Chemotherapy induced thrombocytopenia in pediatric oncology. (se deschide o fereastră nouă)

Tamamyan G, Danielyan S, Lambert MP

Sursă‎: Crit Rev Oncol Hematol 2016;99:299-307.

Index‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (se deschide o fereastră nouă)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (se deschide o fereastră nouă)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Sursă‎: Onkologie 2004;27(2):131-7.

Index‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (se deschide o fereastră nouă)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (se deschide o fereastră nouă)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Sursă‎: Ann Oncol 2005;16(1):139-45.

Index‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (se deschide o fereastră nouă)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (se deschide o fereastră nouă)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Sursă‎: Blood 1998;91(10):3601-6.

Index‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (se deschide o fereastră nouă)